Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.3B | 6.4B | 6.3B | 6.4B |
Cost of revenue | 5.0B | 5.3B | 5.0B | 4.9B |
Gross profit | 1.2B | 1.1B | 1.3B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 245M | 289M | 276M | 248M |
Other operating expenses | — | — | — | — |
Operating income | 949M | 804M | 953M | 1.2B |
Non operating interest income | ||||
Income | 9M | 10M | 11M | 9M |
Expense | 192M | 180M | 179M | 173M |
Other income expense | -2M | -36M | 1M | 1M |
Pretax income | 764M | 598M | 786M | 1.0B |
Tax provision | 99M | 143M | 202M | 268M |
Net income | 665M | 455M | 584M | 772M |
Basic EPS | 2.4 | 1.6 | 2.1 | 2.7 |
Diluted EPS | 2.4 | 1.6 | 2.1 | 2.7 |
Basic average shares | 276.9M | 278.9M | 281.5M | 285.8M |
Diluted average shares | 277.7M | 280.1M | 281.5M | 286.7M |
EBITDA | 1.1B | 1.1B | 1.0B | 1.3B |
Net income from continuing op. | 665M | 455M | 584M | 772M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |